Difficulties in getting Covid-19 vaccines from the US and Europe to Africa mean that it’s more important than ever for the continent to be capable of breakthrough research in biotechnology and medicine. While that reality may still be years away, new investment into one of the continent’s most ambitious health-tech companies could help lay necessary foundations.54gene, the genomics research startup, says it has raised $25 million in a Series B round led by venture capitalists Cathay AfricInvest Innovation Fund. Some existing investors like Adjuvant Capital, KdT Ventures, and Ingressive Capital put in new money too.Abasi Ene-Obong, 54gene’s CEO, says the new capital will advance plans for “an
Hence then, the article about africa s top dna research startup has secured 25 million for drug discovery and pharma talent was published today ( ) and is available onQuartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Africa’s top DNA research startup has secured $25 million for drug discovery and pharma talent )